CFDE Data Portal | Search LINC02694

	Label	Description
	LINC02694 Gene (Entity type)	ENSG00000175779 - long intergenic non-protein coding RNA 2694
	GSE138937 Rad21 CTCF knockdown SLK 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173483 nutlin-3 U2OS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 dasatinib 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE228357 OGA knockdown 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE113655 phenol 3 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE79395 ADNP knockdown HCT 116 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE203329 HCC knockout 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE112202 digoxin 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC02694

ENSG00000175779 - long intergenic non-protein coding RNA 2694

GSE138937 Rad21 CTCF knockdown SLK 2 v 1 human up

A Gene Set from LINCS

GSE173483 nutlin-3 U2OS 1 v 0 human dn

A Gene Set from LINCS

GSE218060 decitabine T cell 1 v 3 human up

A Gene Set from LINCS

GSE135514 dasatinib 2 v 3 human up

A Gene Set from LINCS

GSE228357 OGA knockdown 5 v 1 human dn

A Gene Set from LINCS

GSE113655 phenol 3 v 6 human dn

A Gene Set from LINCS

GSE79395 ADNP knockdown HCT 116 0 v 1 human dn

A Gene Set from LINCS

GSE203329 HCC knockout 0 v 3 human dn

A Gene Set from LINCS

GSE112202 digoxin 5 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.